Meet Sentante’s CEO Edvardas Satkauskas | Interview by Joe Mullings
June 20, 2025
June 20, 2025
Joe Mullings sits down with Edvardas Satkauskas, CEO of Sentante, to discuss the company’s groundbreaking work in robotic surgery and the future of MedTech.
Our latest
news and publications
news and publications
-
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025 -
Read
Critical Stroke Procedure Performed from Across the AtlanticNovember 11, 2025